Thermo Fisher Scientific completes acquisition of Solventum’s purification and filtration business

Thermo Fisher Scientific has announced its acquisition of the Purification & Filtration business of Solventum. With the transaction complete, the business, which is now Thermo Fisher’s Filtration and Separation business, is part of the Life Sciences Solutions segment.

The transaction includes Solventum’s Purification & Filtration business serving Bioprocessing Filtration, Healthcare and Industrial Filtration, and Membranes. The business strengthens Thermo Fisher’s bioproduction offerings with advanced filtration technologies that improve quality and efficiency across upstream and downstream workflows.

In addition, the robust industrial filtration and membrane solutions will expand Thermo Fisher's reach into industries requiring ultra-pure water, including battery, semiconductor and medical device manufacturing.

“We are delighted to welcome the Filtration and Separation colleagues to Thermo Fisher,” said Marc N. Casper, chairman, president and chief executive officer of Thermo Fisher. “The addition of innovative filtration technologies is highly complementary and expands our bioprocessing portfolio to better serve the end-to-end needs of our pharma and biotech customers in this rapidly growing market. It also provides opportunities to broaden our reach in adjacent markets with attractive growth.”

Want the latest science news straight to your inbox? Become a SelectScience member for free today>>